Come up with a name for your new list and we'll add to it:
Diabetogen Biosciences raised a round of funding on , . Investors include
BDC Venture Capital.
Diabetogen is a biotechnology company that discovers and develops new drugs for autoimmune diseases. Diabetogen's initial programs focus on the development of novel therapeutics for the treatment, pre…